Form 4 for CRDF Cardiff Oncology, Inc.
Accepted 2024-12-12 00:00:00 ET · period of report 2024-12-11 · accession 0000950170-24-135767 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-12-12 | 2024-12-11 | CRDF | PACE GARY W | Dir | P - Purchase | $2.60 | +11.5K | 1.06M | +1% | +$29.9K |
| 2024-12-12 | 2024-12-11 | CRDF | PACE GARY W | Dir | P - Purchase | $2.60 | +350.1K | 1.05M | +50% | +$910.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-11 | P | A | 11,500 | $2.60 | 1,059,376 | I | — | — | |
| 2 | Common | Common Stock | 2024-12-11 | P | A | 350,115 | $2.60 | 1,047,876 | D By minor child | — | — |